Article Details

Pfizer selects once-daily obesity drug for advancement - Pharmafile

Retrieved on: 2024-07-12 16:13:10

Tags for this article:

Click the tags to see associated articles and topics

Pfizer selects once-daily obesity drug for advancement - Pharmafile. View article details on hiswai:

Excerpt

Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates.

Article found on: pharmafile.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up